TaiMed Biologics (4147) — Cash Flow Quality Index

Latest as of March 2021: -53.13x

TaiMed Biologics (4147) has a Cash Flow Quality Index of -53.13x as of March 2021. Operating cash flow of NT$-261.15 Million is below net income of NT$4.92 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 4147 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-53.13x

Operating CF / Net Income

Operating Cash Flow

NT$-261.15 Million

TWD

Net Income

NT$4.92 Million

TWD

Data as of

Mar 2021

Most recent filing

Annual Cash Flow Quality Index for TaiMed Biologics (None–None)

Year-by-year earnings quality comparison for TaiMed Biologics. For live market cap and the full company financial profile, see TaiMed Biologics stock valuation.

Year	Quality Index	Operating CF (TWD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.